NFON representatives present a cheque to Drs. David Rodenhiser and Chris Pin.

From left to right: Birgit Grimberger, General Director, Neurofibromatosis Ontario (NFON); Sonya Corson, President, NFON; Dr. David Rodenhiser, Children’s Health Research Institute (CHRI) scientist; Nicole Goudreau, Marketing Coordinator, NFON and her daughter, Neveah Sosa; and Dr. Chris Pin, Chair and Scientist, Division of Genetics & Development, CHRI.

Epigenetics may lead to new treatments for neurofibromatosis

Children's Health Research Institute - 

Neurofibromatosis (NF) is a genetic disorder that causes tumours to grow along nerves and can affect the development of non-nervous tissues such as bones and skin. The worldwide incidence of NF1 (the most common of the three types of NF) is one in 2,500 to one in 3,000 individuals. Many patients inherit NF1 but it is estimated that about 50 per cent of cases occur as a result of spontaneous gene mutations.

Dr. Bob Teasell and his research team

Showcasing research and fostering collaboration

St. Joseph’s: Parkwood Institute - 

Parkwood Institute Research (PIR) hosted an interactive and festive open house for research teams, partners, patients and families, and members of the public on Friday, Dec. 1. A program of Lawson Health Research Institute, and located within both buildings of St. Joseph’s Health Care London’s Parkwood Institute, PIR represents three major research programs in the areas of cognitive vitality and brain health, mobility and activity and mental health.